重建的叙述:通过三个印度乳腺癌回忆录,超越传记上的破坏
Mahua Bhattacharyya1, Ajit K Mishra1
1Indian Institute of Technology (BHU) Varanasi, India.
Health (London, England : 1997)
|February 19, 2025
概括
患有乳腺癌 (BC) 的印度女性通过叙事重建来驾羞耻和改变身体形象. 他们使用幽默,灵性和开放的沟通来应对,治愈和赋予自己权力.
科学领域:
- 文学研究 文学研究
- 医学人文学科 医学人文学科
- 文化研究 文化研究
背景情况:
- 西方乳腺癌 (BC) 研究广泛记录了羞耻对患者的影响.
- 印度的BC回忆录未被充分探索,特别是关于羞耻的细微差别.
- 了解印度女性BC患者的羞耻感需要集中叙事分析.
研究的目的:
- 检查印度女性BC患者在羞耻方面面临的独特挑战.
- 分析传记中断,改变身体形象和羞耻感如何影响他们的叙述.
- 为了探索应对机制和自传的重建在印度的BC回忆录.
主要方法:
- 对三个印度乳腺癌回忆录的定性分析:"阳光" (2011),"为了癌症,用爱" (2015),和"癌症,你选择了错误的女孩" (2021).
- 专注于叙事理解和羞耻和自我感知的表达.
- 在叙事中识别应对策略和重建行为.
主要成果:
- 印度女性BC叙述者表达了与传记中断和改变身体形象相关的耻辱经历.
- 识别的各种应对策略包括幽默,正常化乳房谈话,灵性和分享生存经验.
- 重建的行为出现了为导航BC挑战授权策略.
结论:
- 印度的BC回忆录揭示了耻辱,身份和治愈的复杂交叉点.
- 自传重建提供了一个超越羞耻和赋予患者权力的机制.
- 叙事分析提供了关于印度女性患有乳腺癌的经历的见解.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancers Originate from Somatic Mutations in a Single Cell
11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Cancer
47.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.4K
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321


